PHARMACIELO LTD (PCLO.CA) Stock Price & Overview

TSX-V:PCLOCA71716K1012

Current stock price

0.045 CAD
0 (0%)
Last:

The current stock price of PCLO.CA is 0.045 CAD. Today PCLO.CA is down by 0%. In the past month the price decreased by -18.18%. In the past year, price decreased by -50%.

PCLO.CA Key Statistics

52-Week Range0.025 - 0.165
Current PCLO.CA stock price positioned within its 52-week range.
1-Month Range0.04 - 0.085
Current PCLO.CA stock price positioned within its 1-month range.
Market Cap
8.455M
P/E
N/A
Fwd P/E
N/A
EPS (TTM)
-0.02
Dividend Yield
N/A

PCLO.CA Stock Performance

Today
0%
1 Week
-18.18%
1 Month
-18.18%
3 Months
-55.00%
Longer-term
6 Months -10.00%
1 Year -50.00%
2 Years -73.53%
3 Years -85.48%
5 Years -96.54%
10 Years N/A

PCLO.CA Stock Chart

PHARMACIELO LTD / PCLO Daily stock chart

PCLO.CA Technical Analysis

ChartMill assigns a technical rating of 0 / 10 to PCLO.CA. When comparing the yearly performance of all stocks, PCLO.CA is a bad performer in the overall market: 98.2% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

PCLO.CA Fundamental Analysis

ChartMill assigns a fundamental rating of 1 / 10 to PCLO.CA. PCLO.CA has a bad profitability rating. Also its financial health evaluation is rather negative.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

PCLO.CA Earnings

Next Earnings DateN/A
Last Earnings DateFeb 27, 2026
PeriodQ3 / 2026
EPS Reported
Revenue Reported
EPS Surprise %
Revenue Surprise %

PCLO.CA Forecast & Estimates


Analysts
Analysts80
Price TargetN/A
EPS Next YN/A
Revenue Next YearN/A

PCLO.CA Groups

Sector & Classification

Sub-Industry
Pharmaceuticals
Index Membership

PCLO.CA Financial Highlights

Over the last trailing twelve months PCLO.CA reported a non-GAAP Earnings per Share(EPS) of -0.02. The EPS increased by 53.63% compared to the year before.


Income Statements
Revenue(TTM)2.30M
Net Income(TTM)-4.51M
Industry RankSector Rank
PM (TTM) N/A
ROA -52.64%
ROE N/A
Debt/Equity N/A
Chartmill High Growth Momentum
EPS Q2Q%125.58%
Sales Q2Q%-46.21%
EPS 1Y (TTM)53.63%
Revenue 1Y (TTM)-33.77%

PCLO.CA Ownership

Ownership
Inst Owners0.18%
Shares187.89M
Float160.75M
Ins Owners9.07%
Short Float %N/A
Short RatioN/A

About PCLO.CA

Company Profile

PCLO logo image PharmaCielo Ltd. operates as a pharmaceutical company. The company is headquartered in Toronto, Ontario. The company went IPO on 2018-01-30. The firm has two subsidiaries, PharmaCielo Colombia Holdings S.A.S. (PharmaCielo Colombia) and Ubiquo Telemedicina S.A.S. (Ubiquo). PharmaCielo Colombia cultivates and processes the Company’s all-natural cannabis into standardized, medicinal-grade dried cannabis flower, cannabis oil extracts and cannabis-related products sold in bulk to pharmaceutical companies and medicinal cannabis distributors globally. In Colombia, PharmaCielo Colombia is a fully licensed cultivator, producer, and distributor of both TetraHydroCannabinol and Cannabidiol medical cannabis. Ubiquo is a knowledge management and medical consultation system. Ubiquo is a technology platform and a user interface that allows doctors and patients to communicate.

Company Info

IPO: 2018-01-30

PHARMACIELO LTD

82 Richmond Street East

TORONTO ONTARIO M5C 2V6 CA

CEO: David Attard

Employees: 0

PCLO Company Website

PCLO Investor Relations

Phone: 14163158741.0

PHARMACIELO LTD / PCLO.CA FAQ

What does PHARMACIELO LTD do?

PharmaCielo Ltd. operates as a pharmaceutical company. The company is headquartered in Toronto, Ontario. The company went IPO on 2018-01-30. The firm has two subsidiaries, PharmaCielo Colombia Holdings S.A.S. (PharmaCielo Colombia) and Ubiquo Telemedicina S.A.S. (Ubiquo). PharmaCielo Colombia cultivates and processes the Company’s all-natural cannabis into standardized, medicinal-grade dried cannabis flower, cannabis oil extracts and cannabis-related products sold in bulk to pharmaceutical companies and medicinal cannabis distributors globally. In Colombia, PharmaCielo Colombia is a fully licensed cultivator, producer, and distributor of both TetraHydroCannabinol and Cannabidiol medical cannabis. Ubiquo is a knowledge management and medical consultation system. Ubiquo is a technology platform and a user interface that allows doctors and patients to communicate.


Can you provide the latest stock price for PHARMACIELO LTD?

The current stock price of PCLO.CA is 0.045 CAD.


What is the dividend status of PHARMACIELO LTD?

PCLO.CA does not pay a dividend.


How is the ChartMill rating for PHARMACIELO LTD?

PCLO.CA has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 1 out of 10.


Which stock exchange lists PCLO stock?

PCLO.CA stock is listed on the TSX Venture Exchange exchange.